VANTA HOLDINGS INC.
No enriched coverage for $VNTXF in the last 7 days.
No SEC Form 4 filings for $VNTXF in the last 30 days.
See all $VNTXF insider activity →Vanta Holdings Inc. (CSE:VNTA, OTC:VNTXF) closed the second tranche of a non-brokered private placement, raising C$210,000 by issuing 210,000 units at C$1.00. Each unit includes a share and a warrant exercisable at C$1.25 until Oct. 15, 2028.
Vanta Holdings Inc. (CSE:VNTA, OTC:VNTXF) closed the second tranche of its private placement, raising C$2.1M. The funds will be used for payables, indebtedness, and corporate awareness. The company also noted the launch of the REX Peptide ETF, which tracks peptide-based companies, though Vanta is not affiliated. Vanta plans a U.S.-focused peptide platform, subject to funding and regulatory compliance.
Vanta Holdings Inc. (CSE:VNTA, OTC:VNTXF) closed the second tranche of a non-brokered private placement, raising C$210,000 by issuing 210,000 units at C$1.00. Each unit includes a share and a warrant exercisable at C$1.25 until Oct. 15, 2028.
Vanta Holdings Inc. (CSE:VNTA, OTC:VNTXF) closed the second tranche of its private placement, raising C$2.1M. The funds will be used for payables, indebtedness, and corporate awareness. The company also noted the launch of the REX Peptide ETF, which tracks peptide-based companies, though Vanta is not affiliated. Vanta plans a U.S.-focused peptide platform, subject to funding and regulatory compliance.
AlphAI scores every news story that mentions VNTXF with an AI model for sentiment and relevance, and aggregates insider trades from VANTA HOLDINGS INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Vanta Holdings Inc. (CSE:VNTA, OTC:VNTXF) closed the second tranche of a non-brokered private placement, raising C$210,000 by issuing 210,000 units at C$1.00. Each unit includes a share and a warrant exercisable at C$1.25 until Oct. 15, 2028.
3 min readVanta Holdings Inc. (CSE:VNTA, OTC:VNTXF) closed the second tranche of its private placement, raising C$2.1M. The funds will be used for payables, indebtedness, and corporate awareness. The company also noted the launch of the REX Peptide ETF, which tracks peptide-based companies, though Vanta is not affiliated. Vanta plans a U.S.-focused peptide platform, subject to funding and regulatory compliance.
1 min read